Celltrion fined in South Korea over cancelled Covid-19 test kit orders
MLex Summary: South Korean biopharmaceutical company Celltrion has been fined 630 million won ($472,000) for unfair subcontracting practices involving the production of Covid-19 rapid diagnostic test kits, including the unilateral cancellation of...To view the full article, register now.
Already a subscriber? Click here to view full article